Ares Capital (ARCC) ended the recent trading session at $17.96, demonstrating a -1.26% change from the preceding day's closing price. This move was narrower than the S&P 500's daily loss of 1.51%.

Ares Capital (ARCC) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Over ...

Quit the rat race with income investing: build reliable cash flow, reinvest 25% to buy more in down markets, and avoid gambling on market highs. Read more now.

CION's 17.9% yield grabs attention, but rising credit stress, weak price trends raise doubts about how sustainable that ...

Morgan Stanley Direct Lending Fund (MSDL) and Energy Transfer (ET) offer discounts, strong coverage, and growth—read more ...

Dividend stocks have been in high demand this year as investors seek a safe haven from stock market volatility. Good dividend ...

Ares Capital Corp is a traded fund invests in companies located in the United States and Canada with an EBITDA of USD 10 - 250 million. The fund targets companies operating in the fields of health ...

CION Investment's 2026 outlook hinges on deal flow recovery, rising competition and credit risks as shifting markets test origination growth and returns.

CION Investment Corp. CION is facing a tougher mix of fundamentals and sentiment. Credit performance is becoming a more central swing factor, and book value has already taken a meaningful hit. At the ...

Arcellx develops cell-based immunotherapies for cancer, leveraging proprietary platforms to address high unmet needs in ...

Accelerant Holdings (NYSE:ARX) is one of the 11 best insurance stocks to buy right now. Back on February 23, Paul Newsome ...